law. The effort was unsuccessful.... Thank God! More recently, the industry attempted to influence the ongoing debate about changes to the Food and Drug Administration's nutrition facts label. One of the key changes currently being mulled is the inclusion of an "added sugar" label, which is meant to communicate how m

loping drugs for the treatment of low 20 sexual interest, desire, and/or arousal in women.2 Specifically, this guidance addresses the Food 21 and Drug Administration's (FDA's) current thinking regarding the overall clinical development 22 program, with a focus on phase 3 trial designs, to support an indication for